MediPharm Labs Corp. (TSE:LABS – Get Free Report) shares fell 6.7% on Thursday . The stock traded as low as C$0.07 and last traded at C$0.07. 107,441 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 376,219 shares. The stock had previously closed at C$0.08.
MediPharm Labs Trading Down 6.7 %
The company has a quick ratio of 3.10, a current ratio of 3.11 and a debt-to-equity ratio of 5.90. The stock’s 50 day moving average is C$0.07 and its 200-day moving average is C$0.07. The company has a market cap of C$28.77 million, a PE ratio of -1.75 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Read More
- Five stocks we like better than MediPharm Labs
- What is MarketRank™? How to Use it
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
- What Does Downgrade Mean in Investing?
- 3 Smart Picks: Discounted Stocks for Savvy Investors
- What to Know About Investing in Penny Stocks
- NVIDIA Deal Ignites Aurora Stock’s Explosive Potential
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.